Your browser doesn't support javascript.
loading
Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18-64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials.
Ward, Brian J; Makarkov, Alexander; Séguin, Annie; Pillet, Stéphane; Trépanier, Sonia; Dhaliwall, Jiwanjeet; Libman, Michael D; Vesikari, Timo; Landry, Nathalie.
Afiliação
  • Ward BJ; Medicago, Quebec, QC, Canada; Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
  • Makarkov A; Medicago, Quebec, QC, Canada.
  • Séguin A; Medicago, Quebec, QC, Canada.
  • Pillet S; Medicago, Quebec, QC, Canada.
  • Trépanier S; Medicago, Quebec, QC, Canada.
  • Dhaliwall J; Medicago, Quebec, QC, Canada.
  • Libman MD; Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
  • Vesikari T; Nordic Research Network Oy, Tampere, Finland.
  • Landry N; Medicago, Quebec, QC, Canada. Electronic address: landryn@medicago.com.
Lancet ; 396(10261): 1491-1503, 2020 11 07.
Article em En | MEDLINE | ID: mdl-33065035
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Vacinas de Produtos Inativados / Influenza Humana Tipo de estudo: Clinical_trials / Guideline Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Vacinas de Produtos Inativados / Influenza Humana Tipo de estudo: Clinical_trials / Guideline Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article